Insulin and Insulin Pulses During Fasting
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06424015
- Status
- Recruiting
Conditions
- PreDiabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Intralipid and heparin — OTHERIntralipid (20%, 0.011ml/kg/min; Baxter, Healthcare, Deerfield, IL) and heparin (200 units prime, 0.2 unit/kg/min continuous) will be infused to induce acute insulin resistance
- Saline — OTHERSaline will be infused
Study Details
Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed experiment is part of a series of experiments designed to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.
Key Dates
- Start date
- Sep 15, 2024
- Status verified
- Sep 2025
- Primary completion
- Sep 1, 2026
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Intralipid and heparinBetween 0600 (-180 min) and 1300 (240 min) Intralipid (20%, 0.011ml/kg/min; Baxter, Healthcare, Deerfield, IL) and heparin (200 units prime, 0.2 unit/kg/min continuous) will be infused to induce acute insulin resistance.
- Placebo Comparator: SalineBetween 0600 (-180 min) and 1300 (240 min) saline will be infused
Primary Outcome Measure
Suppression of Endogenous glucose production (EGP) by insulin [ Time Frame: The rate of EGP at 240 minutes (end of study) expressed as a percentage of fasting EGP (at the start of the study i.e.: 0 minutes. ]
Central Contacts
- Kim Osmundson, CCRP507-255-0907
- Jeanette Laugen507-255-8110
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsRecruiting · Cleerly, Inc. · Chandler, Arizona
- Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover TrialRecruiting · University of Minnesota · Lake Forest, Illinois
- Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 DiabetesRecruiting · Mayo Clinic · Rochester, Minnesota
- The Role of Islet GLP-1 in the Pathogenesis of PrediabetesPHASE2 · Recruiting · Mayo Clinic · Rochester, Minnesota